Korea Quality Re-Rating Watch 2026-10-13: Micro Contact Sol, Pan Ocean

Tue, 13 Oct 2026 16:30:00 +0900

Macro Dashboard

Indicator	Value	5-Day Change	Signal
KOSPI	6,035.4	−13.1%	Bear
KOSDAQ	837.0	−9.0%	Bear
VIX	15.6	+3.3%	Stable
US 10Y	5.24%	−0.03pp	Neutral
USD/KRW	1,340	+0.1%	Neutral
Brent	$104.7	+0.4%	Stable

Regime: Korea = Bear · US = Bull · Stance: reduce KR, hold US.

KOSPI breadth remains compressed — 39% of names above the 50-day MA, 23% above the 200-day MA. Program selling dominated: market program flow was −₩2.06 trillion on the day, ETF net creation −₩1.53 trillion. Basis held at +2.73, but the derivative/passive pressure is the primary KR bear driver, not a macro shock. The KR-US regime split is confirmed and widening.

Market Wrap

Source: KR Market Snapshot (same-day DB, 2026-10-13). No full close briefing was available; a prior-session briefing was intentionally excluded.

Today was another broad retreat. Of 2,595 listed names, 1,737 fell and only 613 advanced — an advance-decline ratio of 35.3. The average stock dropped 1.04%. The session had no dominant sector story; it was program-led index pressure pulling the tape lower across the board.

What held: Institutions stepped in selectively on large-cap names. LG Energy Solution (373220.KS, +3.0%), SK Innovation (096770.KS, +2.6%), and Meritz Financial Group (138040.KS, +2.2%) closed higher. HPSP (403870.KQ, +0.9%) and DB Non-Life Insurance (005830.KS, +0.9%) also closed green.

What was hit: Consumer beauty and mid-cap domestic themes absorbed the most selling. Pharma Research (214450.KQ, −8.1%), Korea Kolmar (161890.KS, −7.7%), Silicon2 (257720.KQ, −6.7%), and SK (034730.KS, −7.4%) led declines.

Foreign flow: Scattered and counter-trend. Foreigners net-bought VM (089970.KQ), Pharma Research (214450.KQ), and Samhwa Capacitor (001820.KS) even as prices fell — position-building into weakness rather than momentum. They were net sellers of LG Energy Solution (373220.KS), KB Financial (105560.KS), and SK (034730.KS).

Institutional flow: Institutions bought LG Energy Solution, Hyundai Motor (005380.KS), KB Financial, and HPSP against the tape — consistent with benchmark rebalancing rather than fresh conviction. They sold VM, Silicon2, Pharma Research, and Samhwa Capacitor, creating a clean institutional-vs-foreign split in mid-cap names where the two investor types took opposite sides of the same stocks.

The key signal is the OI increase of +13,424 contracts alongside heavy program selling — consistent with index futures hedging, not directional shorting. Until program flows normalize, individual stock selectivity remains the better approach over broad index exposure.

Today’s Quality Re-Rating Candidates

Primary source: KR Meta Screener, 2026-10-13. PEAD screener latest available: 2026-10-09 (same-day PEAD output absent; meta screener marks PEAD as empty). Screener intersection shows no 2+ raw overlaps today, so Meta Screener rank and evidence-family count drive candidate order.

Despite the broad decline, the screening framework identifies names where institutional and foreign money is absorbing retail supply — the foundational setup for quality re-rating. The top candidates combine at least two independent evidence families: fundamental quality, smart money flow, earnings/cycle momentum, or official DART catalyst.

Candidate Table

Rank	Ticker	Name	Meta Score	Screeners / Evidence Signals	Key Metrics	DART
1	098120.KQ	Micro Contact Sol	56.6	Quality + Smart Money Q + Cycle Rerating + Smart Money Earnings + Surface	ROE 23.1%, OP YoY +73.5%, margin +3.0pp	1 filing
2	252990.KQ	SamC&S	52.2	Quality + Cycle Rerating + Surface	ROE 9.7%, OP YoY +182.7%, margin +9.1pp	None
3	096530.KQ	Seegene	51.0	Quality + Cycle Rerating + Surface	ROE 4.8%, OP YoY +309.7%, margin +11.3pp	1 catalyst
4	028670.KS	Pan Ocean	49.8	Smart Money Q + Smart Money Earnings + RS80 + Surface	5-day F+QI net +₩21.4bn, retail −₩19.5bn	2 catalysts
5	033780.KS	KT&G	49.1	Quality + RS80 + Surface	ROE 11.7%, OP YoY +13.0%, foreign ownership 51.2%	2 catalysts (buyback + cancellation)
6	204620.KQ	Global Tax Free	49.0	Quality + RS80 + Surface	ROE 27.8%, OP YoY +34.3%, pivot gap +6.0%	2 filings
7	443060.KS	HD Hyundai Marine Solution	44.4	Quality + Cycle Rerating + Surface	ROE 33.7%, OP YoY +28.9%, margin +2.1pp	1 catalyst (IR)
8	025560.KS	Mirae Industry	43.1	Quality + Surface	ROE 8.8%, OP YoY −24.8%	2 supply contracts
9	353200.KQ	Daeduck Electronics	40.6	Smart Money Q + Cycle Rerating + Smart Money Earnings + Surface	5-day F+QI net +₩17.6bn, retail −₩31.6bn	1 filing
10	219130.KQ	Tiger Elec	38.0	Quality + Surface	ROE 9.5%, OP YoY flat	None

Top 3 in Focus

#1 — Micro Contact Sol (098120.KQ) makes semiconductor test sockets — the precision contact hardware used in chip testing at IC manufacturers. It is the only name in today’s screen that fires all five signal families simultaneously: Quality Compounder (ROE 23.1%, OP up 73.5% YoY, margin expansion +3.0pp), Smart Money Quality (foreigners and quality institutions net-absorbed ₩7.8bn over 5 days while individuals sold ₩9.2bn), Cycle Rerating, Smart Money Earnings, and Kiwoom market surface confirmation. The PEAD screener from Oct 9 also places it in Tier A with a 73.5% OP beat — cross-validation across two independent data pipelines. DART has one filing: an executive shareholding disclosure on Oct 8 (neutral). Next check: whether the OP beat is driven by volume ramp or unit pricing improvement, and whether sell-side consensus has revised forward estimates upward following the most recent quarter.

#2 — SamC&S (252990.KQ) is a semiconductor materials and components supplier. The +182.7% OP YoY growth and +9.1pp margin expansion are the largest margin inflection numbers in today’s top 10. Cycle Rerating and Quality Compounder both fire. The Kiwoom surface shows institutional accumulation (rank #439 by institutional count), foreigners net buying, program flow +7.4%, and short interest at a low 2.8% — relatively clean positioning with little technical overhead. No DART filings in the 21-day lookback window. Next check: what is driving the OP surge — structural (new contract mix, capacity utilization) or one-time — and whether the margin expansion is repeatable at current revenue levels.

#3 — Seegene (096530.KQ) is Korea’s leading molecular diagnostics platform, most recognized for its COVID-era revenue surge. The OP YoY of +309.7% is a base-effect comparison, so the more durable data point is the +11.3pp margin expansion. Individuals sold ₩15.4bn while foreigners and quality institutions absorbed supply, and the Kiwoom surface confirms positive institutional and financial investor flow. A DART catalyst is on record: Q3 interim dividend record date (Sep 28), adding a shareholder-return signal. Caution flags apply: short interest is elevated at 7.3%, program flow at +18.4% is passive-driven rather than conviction buying, the order book shows a +59% bid-ask imbalance, and the foreign broker channel was net-selling. This is a screened candidate, not a clean setup — position sizing and entry timing require additional verification. Next check: revenue trajectory in diagnostics excluding COVID kits, and any new product cycle in molecular or AI-assisted pathology.

Notable Beyond the Top 3

Pan Ocean (028670.KS) carries 6 independent evidence signals — the highest count in today’s screen — combining Smart Money Quality, Smart Money Earnings, RS80 leadership (Focus Candidate, pivot gap +1.7%), and two DART supply contract catalysts (Oct 1 and Sep 28). However, the foreign-vs-institutional flow split is inverted: foreigners are net sellers while quality institutions are buying. Short interest at 7.1% is also not trivial. The 6-signal convergence warrants attention, but the flow divergence needs a clean read before treating this as a straightforward accumulation setup.

KT&G (033780.KS) adds a shareholder return angle rarely seen in a bear-regime session. DART records both a share repurchase decision and a treasury stock cancellation (both Sep 22 catalysts). With 51.2% foreign ownership already near capacity, the marginal catalyst is float compression from the buyback, not new foreign entry. Quality Compounder and RS80 Not-Late both confirm, and quality-institution flow is positive — worth monitoring for a bottoming signal if the broader bear regime begins to lift.

All data sourced from Research OS internal screeners as of 2026-10-13. This post is public market analysis only and does not constitute investment advice.